The biotechnology industry group, which remains one of the year’s hottest, has a couple of stocks in the IPO Leaders screen. One is Intrexon (XON), which is trading near the 47.90 buy point of a cup-with-handle base. The company, like many new biotechs, has been posting losses and is expected to lose money again this year and next. It did earn profits the past two quarters, but its sales growth is what is most impressive.